San Francisco, 19 November 2018: According to a report by Grand View Research, Inc.; the global cartilage repair market is anticipated to reach USD 6.7 billion by 2025. Growing prevalence of joint and bone disorders such as arthritis and osteoporosis (OA) is anticipated to fuel market growth over the forecast period (2018 to 2025).
Increasing number of geriatric population being prone to various bone and joint related problems can positively influence growth of market for cartilage repair. Rising cases of obesity and diabetes leading to cartilage loss can further surge demand. Increasing number of road accidents and sports related injuries globally can result in severe bone and joint related injuries. This, in turn, can fuel demand for cartilage repair products during the forecast period.
The worldwide cartilage repair market can be segregated on the basis of treatment modality, application, treatment type, site, and region. Based on treatment modality, the market can be divided into cell-based and non-cell based. In 2016, cell-based segment accounted for largest market share. It is expected to grow at similar pace over the forecast period. Rising preference for autologous chondrocyte transplants for surgical treatment of damaged articular cartilage can fuel growth in near future. Non-cell based segment can be divided further into cell-free composites and tissue scaffolds. Tissue scaffold stimulate cartilage and bone growth when transplanted into knees and other joints. Hence, they are extensively used as compared to cell-free composite.
Access Research Report of Cartilage Repair/Regeneration [email protected] www.grandviewresearch.com/industry-analysis/cartilage-repair-regeneration-market
Based on application, the market can be bifurcated into hyaline cartilage and fibrocartilage. Hyaline cartilage is predicted to dominate the market over the forecast period. Rising cases of physical trauma can cause chondral lesions and osteochondral in patients. The segment is expected to witness significant growth during the forecast period owing to high susceptibility of damage to hyaline cartilage due to injuries. In addition, surge in sports related traumas to can result in articular cartilage defects of knee and other joints. This factor can further fuel market growth.
Based on treatment type, the market can be categorized into palliative and intrinsic repair stimulus. In 2016, intrinsic repair stimulus held the largest market share. Extensive use of microfracture technique during cartilage repair surgeries can fuel adoption over the forecast period. Intrinsic repair stimulus includes drilling and microfracture techniques that stimulate Mesenchymal Stem Cells (MSC) to the site of injured cartilage to form repair tissue.
On the other hand, palliative segment can be further categorized into viscosupplementation and debridement and lavage. Viscosupplementation involves injecting hyaluronic acid into joints to replace or supplement synovial fluid for treatment of osteoporosis of toe, thumb, and other small joints. The segment is anticipated to witness significant growth over the forecast period due to rising demand for hyaline-like regeneration of cartilage.
Based on site, the market for cartilage repair can be classified into knee cartilage repair and others. Knee cartilage repair segment is expected to dominate the market over the forecast period attributed to higher usage in repair procedures. Rising cases of osteoporosis and increasing incidents of accident injuries can drive expansion over the forecast period.
Regional segmentation includes Europe, North America, Asia Pacific, Latin America, and Middle East and Africa (MEA). In 2016, North America dominated the market and accounted for 50% market share. Rising cases of musculoskeletal diseases coupled with presence of target population can fuel regional market growth. In addition, changing lifestyle of individuals in Canada and U.S. can further augment market over the next few years. Europe is estimated to witness significant growth owing to high prevalence of osteoporosis in Germany, U.K., and France. According to the National Health Service (NHS), osteoporosis affects 3 million people in U.K. every year.
Asia Pacific is predicted to expand at the highest CAGR during the forecast period as compared to other regions. Rising cases of diabetes in Japan, China, and Australia can fuel market growth in the region. In addition, growing cases of osteoporosis and cartilage damage in Australia and New Zealand are expected to stimulate growth of the regional market during the forecast period.
Some of the leading companies in cartilage repair market are DePuy Synthes, Smith & Nephew plc, Zimmer Biomet, Stryker Corporation, and Vericel Corporation. Most companies adopt growth strategies such as acquisitions and merger, product launch, and regional expansions to sustain market competition.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.